Horizon Therapeutics Plc
(NASDAQ : HZNP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MYOKMyoKardia, Inc. 0.37%222.971.8%$514.75m
HZNPHorizon Therapeutics Plc 1.81%77.445.8%$157.77m
VRXValeant Pharmaceuticals International, Inc. 2.00%18.3614.1%$108.03m
JAZZJazz Pharmaceuticals Plc -0.61%150.262.4%$80.09m
CTLTCatalent, Inc. 0.69%94.042.1%$78.96m
BHCBausch Health Cos., Inc. 2.00%18.360.0%$69.59m
UTHRUnited Therapeutics Corp. 0.56%122.7814.1%$49.00m
ICLRICON plc -1.87%194.354.3%$47.08m
SAGESAGE Therapeutics, Inc. 0.97%71.518.6%$44.61m
ENDPEndo International Plc 0.00%5.798.7%$38.62m
ARGXargenx SE -0.72%250.420.0%$37.39m
ZGNXZogenix, Inc. 1.38%21.297.5%$35.17m
AMRNAmarin Corp. Plc -0.80%4.981.5%$33.35m
PRGOPerrigo Co. Plc 0.26%45.606.8%$32.08m
CTICCTI BioPharma Corp. 4.79%3.501.8%$31.00m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.